Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Levine

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Pediatrics|November 17, 2009
Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (cblC) detected through low carnitine levels on newborn screeningHenry J Lin, Julie A Neidich, Denise Salazar, et al.
Plos One|October 17, 2012
Characterizing the mechanism of action of double-stranded RNA activity against western corn rootworm (Diabrotica virgifera virgifera LeConte)Renata Bolognesi, Parthasarathy Ramaseshadri, Jerry Anderson, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Entecavir resistance is rare in nucleoside naïve patients with hepatitis BRichard J Colonno, Ronald Rose, Carl J Baldick, et al.
Stroke|November 3, 2016
Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for NeuroprotectionPatrick Lyden, Sara Weymer, Chris Coffey, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Amy K Sheaffer, Jacques Friborg, et al.
Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily DosingLi-Qiang Sun, Eric Mull, Barbara Zheng, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Pediatrics|November 17, 2009
Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (cblC) detected through low carnitine levels on newborn screeningHenry J Lin, Julie A Neidich, Denise Salazar, et al.
Plos One|October 17, 2012
Characterizing the mechanism of action of double-stranded RNA activity against western corn rootworm (Diabrotica virgifera virgifera LeConte)Renata Bolognesi, Parthasarathy Ramaseshadri, Jerry Anderson, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Entecavir resistance is rare in nucleoside naïve patients with hepatitis BRichard J Colonno, Ronald Rose, Carl J Baldick, et al.
Stroke|November 3, 2016
Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for NeuroprotectionPatrick Lyden, Sara Weymer, Chris Coffey, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Amy K Sheaffer, Jacques Friborg, et al.
Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily DosingLi-Qiang Sun, Eric Mull, Barbara Zheng, et al.
Pageof 3